These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1054 related articles for article (PubMed ID: 27323951)

  • 21. [The role of alternative lengthening of telomeres mechanisms in carcinogenesis and prospects for using an anti-telomerase drugs in malignant tumors treatment].
    Grach AA
    Tsitologiia; 2011; 53(10):759-71. PubMed ID: 22232932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic Targets in Telomerase and Telomere Biology of Cancers.
    Prasad R; Pal D; Mohammad W
    Indian J Clin Biochem; 2020 Apr; 35(2):135-146. PubMed ID: 32226245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Telomere biology of pediatric cancer.
    Tabori U; Dome JS
    Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of telomerase and viruses interaction in cancer development, and telomerase-dependent therapeutic approaches.
    Salimi-Jeda A; Badrzadeh F; Esghaei M; Abdoli A
    Cancer Treat Res Commun; 2021; 27():100323. PubMed ID: 33530025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Compromised Telomeric Heterochromatin Promotes ALTernative Lengthening of Telomeres.
    Voon HPJ; Collas P; Wong LH
    Trends Cancer; 2016 Mar; 2(3):114-116. PubMed ID: 28741530
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomere length abnormalities and telomerase RNA component expression in gastroenteropancreatic neuroendocrine tumors.
    Kim HS; Lee HS; Nam KH; Choi J; Kim WH
    Anticancer Res; 2015 Jun; 35(6):3501-10. PubMed ID: 26026117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Agents that target telomerase and telomeres.
    Raymond E; Sun D; Chen SF; Windle B; Von Hoff DD
    Curr Opin Biotechnol; 1996 Dec; 7(6):583-91. PubMed ID: 8939642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomerase inhibition alters telomere maintenance mechanisms in laryngeal squamous carcinoma cells.
    Chen W; Chen SM; Yu Y; Xiao BK; Huang ZW; Tao ZZ
    J Laryngol Otol; 2010 Jul; 124(7):778-83. PubMed ID: 20403221
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospects for anti-neoplastic therapies based on telomere biology.
    Stewart SA; Hahn WC
    Curr Cancer Drug Targets; 2002 Mar; 2(1):1-17. PubMed ID: 12188917
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biology of telomeres: importance in etiology of esophageal cancer and as therapeutic target.
    Pal J; Gold JS; Munshi NC; Shammas MA
    Transl Res; 2013 Dec; 162(6):364-70. PubMed ID: 24090770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Telomerase Inhibitors from Natural Products and Their Anticancer Potential.
    Ganesan K; Xu B
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29267203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alternative Lengthening of Telomeres (ALT) in Tumors and Pluripotent Stem Cells.
    Zhao S; Wang F; Liu L
    Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31835618
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of ATRX Suppresses Resolution of Telomere Cohesion to Control Recombination in ALT Cancer Cells.
    Ramamoorthy M; Smith S
    Cancer Cell; 2015 Sep; 28(3):357-69. PubMed ID: 26373281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players.
    Yuan X; Larsson C; Xu D
    Oncogene; 2019 Aug; 38(34):6172-6183. PubMed ID: 31285550
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Telomere maintenance as a target for drug discovery.
    Sekaran V; Soares J; Jarstfer MB
    J Med Chem; 2014 Feb; 57(3):521-38. PubMed ID: 24053596
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crossroads of telomere biology and anticancer drug discovery.
    Seimiya H
    Cancer Sci; 2020 Sep; 111(9):3089-3099. PubMed ID: 32579791
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Telomerase-Targeted Cancer Immunotherapy.
    Mizukoshi E; Kaneko S
    Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31013796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of silencing key proteins in telomerase mechanism and alternative lengthening of telomeres mechanism in laryngeal cancer cells.
    Xu Y; Wang X; Chen SM; Chen C; Wang Y; Xiao BK; Tao ZZ
    Am J Otolaryngol; 2016; 37(6):552-558. PubMed ID: 27726944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomeres, telomerase and cancer: an endless search to target the ends.
    Satyanarayana A; Manns MP; Rudolph KL
    Cell Cycle; 2004 Sep; 3(9):1138-50. PubMed ID: 15467446
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Switch telomerase to ALT mechanism by inducing telomeric DNA damages and dysfunction of ATRX and DAXX.
    Hu Y; Shi G; Zhang L; Li F; Jiang Y; Jiang S; Ma W; Zhao Y; Songyang Z; Huang J
    Sci Rep; 2016 Aug; 6():32280. PubMed ID: 27578458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 53.